Literature DB >> 24294037

Validation of the vitronectin knockout mouse as a model for studying myocardial infarction: Vitronectin appears to influence left ventricular remodelling following myocardial infarction.

Gordon E Pate1, Hubert P Walinski, Lubos Bohunek, Thomas J Podor.   

Abstract

BACKGROUND: Vitronectin (VN) is an abundant acute-phase plasma protein that regulates cell adhesion and migration as well as interactions with components of the plasminogen activator/plasmin system, specifically plasminogen activator inhibitor type 1. This system plays a major role in tissue remodelling regulating wound healing after myocardial infarction.
OBJECTIVES: To investigate the feasibility of using VN knockout mice (VN(-/-)) to study the role of VN on ventricular remodelling following myocardial infarction.
METHODS: Specifically bred VN(-/-) mice and normal wild-type (VN(+/+)) mice underwent coronary artery ligation and were assessed 28 days postligation using echocardiography and morphometric histology.
RESULTS: No difference was observed between VN(-/-) mice and VN(+/+) mice with respect to gross phenotype, weight, coronary anatomy or echocardiographically measured ejection fraction (56%). Following myocardial infarction, VN(-/-) mice exhibited less ventricular dilation and less impairment in echocardiographic ejection fraction compared with VN(+/+) mice (48% versus 41%; P=0.01). VN(-/-) mice also exhibited smaller infarcts on morphometric analysis.
CONCLUSIONS: The results of the present study confirmed the feasibility of using coronary artery ligation in VN knockout mice to investigate the role of VN in post-myocardial infarction remodelling. The absence of VN appears to result in favourable effects on wound healing. These data suggest that this model may offer novel insights into the role of VN in the regulation of myocardial remodelling.

Entities:  

Keywords:  Myocardial infarction; Remodelling; Vitronectin

Year:  2013        PMID: 24294037      PMCID: PMC3716488     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  32 in total

1.  Integration of concepts: cardiac extracellular matrix remodeling after myocardial infarction.

Authors:  Jack P M Cleutjens; Esther E J M Creemers
Journal:  J Card Fail       Date:  2002-12       Impact factor: 5.712

2.  Type 1 plasminogen activator inhibitor induces multimerization of plasma vitronectin. A suggested mechanism for the generation of the tissue form of vitronectin in vivo.

Authors:  D Seiffert; D J Loskutoff
Journal:  J Biol Chem       Date:  1996-11-22       Impact factor: 5.157

3.  The use of fluorescent probes to characterize conformational changes in the interaction between vitronectin and plasminogen activator inhibitor-1.

Authors:  A Gibson; K Baburaj; D E Day; I Verhamme; J D Shore; C B Peterson
Journal:  J Biol Chem       Date:  1997-02-21       Impact factor: 5.157

Review 4.  Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling.

Authors:  Y Y Li; C F McTiernan; A M Feldman
Journal:  Cardiovasc Res       Date:  2000-05       Impact factor: 10.787

5.  Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface.

Authors:  Thomas J Podor; Davindra Singh; Paul Chindemi; Denise M Foulon; Robert McKelvie; Jeffrey I Weitz; Richard Austin; Ghislain Boudreau; Richard Davies
Journal:  J Biol Chem       Date:  2001-12-14       Impact factor: 5.157

Review 6.  Matrix metalloproteinase inhibition and the prevention of heart failure.

Authors:  R T Lee
Journal:  Trends Cardiovasc Med       Date:  2001-07       Impact factor: 6.677

Review 7.  Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.

Authors:  J N Cohn; R Ferrari; N Sharpe
Journal:  J Am Coll Cardiol       Date:  2000-03-01       Impact factor: 24.094

8.  Global cardiac remodeling after acute myocardial infarction: a study in the rat model.

Authors:  H F Weisman; D E Bush; J A Mannisi; B H Bulkley
Journal:  J Am Coll Cardiol       Date:  1985-06       Impact factor: 24.094

9.  Plasminogen activator inhibitor-1 impairs alveolar epithelial repair by binding to vitronectin.

Authors:  Michael H Lazar; Paul J Christensen; Ming Du; Bi Yu; Natalya M Subbotina; Kerstin E Hanson; Jean M Hansen; Eric S White; Richard H Simon; Thomas H Sisson
Journal:  Am J Respir Cell Mol Biol       Date:  2004-08-12       Impact factor: 6.914

10.  Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction.

Authors:  Arman T Askari; Marie-Luise Brennan; Xiaorong Zhou; Jeanne Drinko; Annitta Morehead; James D Thomas; Eric J Topol; Stanley L Hazen; Marc S Penn
Journal:  J Exp Med       Date:  2003-03-03       Impact factor: 14.307

View more
  2 in total

1.  Fluid Shear Stress and Fibroblast Growth Factor-2 Increase Endothelial Cell-Associated Vitronectin.

Authors:  Justin G Mathew; Sarah Basehore; Alisa Morss Clyne
Journal:  Appl Bionics Biomech       Date:  2017-06-01       Impact factor: 1.781

Review 2.  The Role of Matrix Proteins in Cardiac Pathology.

Authors:  Katie Trinh; Sohel M Julovi; Natasha M Rogers
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.